Skip to main content
Log in

Nonmodulation and essential hypertension

  • Published:
Current Hypertension Reports Aims and scope Submit manuscript

Abstract

Nonmodulation is a process in which there is a disorder in angiotensin-dependent control of the renal circulation and adrenal aldosterone release. The abnormalities are associated with an inability to handle a sodium load and salt-sensitive hypertension. All of the features are corrected by angiotensin-converting enzyme inhibition. A striking family history of hypertension and concordance of responses to angiotensin II in sibling pairs have suggested a familial factor. Genes governing renin substrate (angiotensinogen) production showed gene polymorphisms in nonmodulators. As nonmodulation occurs in approximately 40% of patients with essential hypertension, clearly other genes must contribute.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References and Recommended Reading

  1. Hollenberg NK, Williams GH: Abnormal renal function, sodium-volume homeostasis and renin system behavior in normal-renin essential hypertension: the evolution of the nonmodulator concept. In Hypertension: Pathophysiology, Diagnosis, and Management, edn 2. Edited by Laragh JH, Brenner BM. New York: Raven Press; 1995:1837–1856. This article is the most complete review of the features of nonmodulation that has been published to date.

    Google Scholar 

  2. Hollenberg NK, Merrill JP: Intrarenal perfusion in the young “essential” hypertensive: a subpopulation resistant to sodium restriction. Trans Assoc Am Physicians 1970, 83:93–101.

    PubMed  CAS  Google Scholar 

  3. Williams GH, Rose LI, Dluhy RG, et al.: Abnormal responsiveness of the renin-aldosterone system to acute stimulation in patients with essential hypertension. Ann Intern Med 1970, 72:317–326.

    PubMed  CAS  Google Scholar 

  4. Hollenberg NK, Chenitz WR, Adams DF, Williams GH: Reciprocal influence of salt intake on adrenal glomerulosa and renal vascular responses to angiotensin II in normal man. J Clin Invest 1974, 54:34–42.

    Article  PubMed  CAS  Google Scholar 

  5. Williams GH, Hollenberg NK: Accentuated vascular and endocrine responses to SQ 20881 in hypertension. N Engl J Med 1977, 297:184–188.

    Article  PubMed  CAS  Google Scholar 

  6. Hollenberg NK, Meggs LG, Williams GH, et al.: Sodium intake and renal responses to captopril in normal man and in essential hypertension. Kidney 1981, 20:240–245.

    CAS  Google Scholar 

  7. Redgrave JE, Rabinowe SL, Hollenberg NK, Williams GH: Correction of abnormal renal blood flow response to angiotensin II by converting-enzyme inhibition in essential hypertensives. J Clin Invest 1985, 75:1285–1290.

    PubMed  CAS  Google Scholar 

  8. Fujita T, Henry WL, Bartter FC, et al.: Factors influencing blood pressure in salt-sensitive patients with hypertension. Am J Med 1980, 69:334–344.

    Article  PubMed  CAS  Google Scholar 

  9. Rystedt LL, Williams GH, Hollenberg NK: The renal and endocrine response to saline infusion in essential hypertension. Hypertension 1986, 8:217–222.

    Google Scholar 

  10. Hollenberg NK, Moore T, Shoback D, et al.: Abnormal renal sodium handling in essential hypertension: relation to failure of renal and adrenal modulation of responses to Ang II. Am J Med 1986, 81:412–418.

    Article  PubMed  CAS  Google Scholar 

  11. Hurwitz S, Fisher NDL, Ferri C, et al.: Controlled analysis of blood pressure sensitivity to sodium intake: interactions with hypertension type. J Hypertension 2003, 21:951–958.

    Article  CAS  Google Scholar 

  12. Williams GH, Hollenberg NK, Moore TJ, et al.: Failure of renin suppression by angiotensin II in hypertension. Circ Res 1978, 4:46–52.

    Google Scholar 

  13. LeBoff MS, Dluhy RG, Hollenberg NK, et al.: Abnormal renin short feedback loop in essential hypertension is reversible with converting enzyme inhibition. J Clin Invest 1982, 70:335–341.

    PubMed  CAS  Google Scholar 

  14. Seely EW, Moore TJ, Rogacz S, et al.: Angiotensin-mediated renin suppression is altered in non-modulating hypertension. Hypertension 1989, 13:31–37.

    PubMed  CAS  Google Scholar 

  15. Williams GH, Tuck ML, Sullivan JM, et al.: Parallel adrenal and renal abnormalities in the young patient with essential hypertension. Am J Med 1982, 72:907–914.

    Article  PubMed  CAS  Google Scholar 

  16. Beretta-Piccoli C, Pusterla C, Stadler P, Weidmann P: Blunted aldosterone responsiveness to Ang II in normotensive subjects with familial predisposition to essential hypertension. J Hypertension 1988, 61:57–61.

    Google Scholar 

  17. Van Hooft IMS, Grobbee DE, Derkx FHM, et al.: Renal hemodynamics and the renin-angiotensin-aldosterone system in normotensive subjects with hypertensive and normotensive parents. N Engl J Med 1991, 324:1305–1311.

    Article  PubMed  Google Scholar 

  18. Uneda S, Fukishima S, Fujika Y, et al.: Renal hemodynamics and renin-angiotensin system in adolescents genetically predisposed to essential hypertension. J Hypertension 1984, 263:437–439.

    Google Scholar 

  19. Guidi E, Cozzi EMMG, Biella E: Sodium physiopathology and nonmodulating hypertension. In Cardiorenal Disease. Contrib Nephrol, vol 106. Edited by Timio M, Wizemann V. Basel, Switzerland: Karger Publishers; 1994:153–156.

    Google Scholar 

  20. Luparini RL, Ferri C, Santucci A, Balsano F: Atrial natriuretic peptide in non-modulating essential hypertension. Hypertension 1993, 21:803–809.

    PubMed  CAS  Google Scholar 

  21. Ferri C, Bellini C, Coassin S, et al.: Abnormal atrial natriuretic peptide and renal responses to saline infusion in nonmodulating essential hypertensive patients. Circulation 1994, 90:2859–2869.

    PubMed  CAS  Google Scholar 

  22. Bigazzi R, Bianchi S, Baldari D, et al.: Microalbuminuria in salt-sensitive patients: a marker for renal and cardiovascular risk factors. Hypertension 1994, 23:195–199.

    PubMed  CAS  Google Scholar 

  23. Sanchez RA, Amos F, Giannone C, et al.: Parallel renal and extremity blood supply abnormalities in nonmodulation. Responses to ACE inhibition. Hypertension 2003, 41:919–924.

    Article  PubMed  CAS  Google Scholar 

  24. Sanchez RA, Ramos F, Giannone C, et al.: Increased microalbuminuria and forearm vascular abnormalities in non-modulating hypertensives and offspring of hypertensives. Similar kidney and peripheral response to ACEI. J Hum Hypertens Suppl 2002, 16:128–132.

    Article  Google Scholar 

  25. Sanchez R, Gimenez MI, Ramos F, et al.: Non-modulating hypertension: evidence for the involvement of kallikrein/ kinin activity associated with overactivity of the renin-angiotensin system. Successful blood pressure control during long-term Na+ restriction. J Hypertension 1996, 14:1287–1291.

    Article  CAS  Google Scholar 

  26. Razin M, Borosh M, Weinstock M: Rabbits with a genetic impairment in baroreceptor reflex sensitivity show abnormal renal haemodynamics and proximal tubular sodium reabsorption in response to a saline infusion. J Hypertens 1993, 11:799–804.

    Article  PubMed  CAS  Google Scholar 

  27. Widgren BR, Herlitz H, Aurell M, et al.: Increased systemic and renal vascular sensitivity to angiotensin II in normotensive men with positive family histories of hypertension. Am J Hypertens 1992, 5:167–174.

    PubMed  CAS  Google Scholar 

  28. Palmgren E, Widgren B, Aurell M, Herlitz H: Increased renal vascular sensitivity to angiotensin II in hypertension is due to decreased respose to prostaglandins. J Hypertens 2003, 21:969–976.

    Article  PubMed  CAS  Google Scholar 

  29. Schachinger H, Dieterle T, Martina B, et al.: Increased renovascular response to angiotensin II in persons genetically predisposed to arterial hypertension disappears after chronic angiotensin-converting enzyme inhibition. J Hypertens 2004, 22:175–180.

    Article  PubMed  Google Scholar 

  30. Lifton RP, Hopkins PN, Williams RR, et al.: Evidence for heritability of non-modulating essential hypertension. Hypertension 1989, 13:884–889.

    PubMed  CAS  Google Scholar 

  31. Williams GH, Dluhy RG, Lifton RP, et al.: Non-modulation as an intermediate phenotype in essential hypertension. Hypertension 1992, 20:788–796.

    PubMed  CAS  Google Scholar 

  32. Hopkins PN, Lifton RP, Hollenberg NK, et al.: Blunted renal vascular response to angiotensin I is associated with a common variant of the angiotensinogen gene and obesity. J Hypertens 1996, 14:199–207. This study ties a specific gene polymorphism to the physiologic features of modulation.

    Article  PubMed  CAS  Google Scholar 

  33. Hopkins PN, Hunt SC, Jeunemaitre X, et al.: Angiotensin genotype effect on renal and adrenal responses to angiotensin II in essential hypertension. Circulation 2002, 105:1921–1927.

    Article  PubMed  CAS  Google Scholar 

  34. Kosachunhanun N, Hunt SC, Hopkins PN, et al.: Genetic determinants of nonmodulating hypertension. Hypertension 2003, 42:901–908.

    Article  PubMed  CAS  Google Scholar 

  35. Klingbeil AU, Jacobi J, Langenfeld MRW, et al.: Enhanced antinatriuresis in response to angiotensin II in essential hypertension. Am J Hypertension 2000, 13:986–993.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Norman K. Hollenberg MD, PhD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hollenberg, N.K., Williams, G.H. Nonmodulation and essential hypertension. Current Science Inc 8, 127–131 (2006). https://doi.org/10.1007/s11906-006-0008-9

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11906-006-0008-9

Keywords

Navigation